CORC

在结果中检索

CORC

浏览/检索结果: 共25条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
BRCANet: A deep hybrid network in predicting BRCA1/2 gene mutation of breast cancer with dynamic contrast-enhanced breast MRI. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Cao, Wen-Ming;  Wang, Xiaojia;  Liu, Jian;  Wang, Lili;  Zhang, Xiaodong
收藏  |  浏览/下载：13/0  |  提交时间：2022/12/23
Adjusting the Si Phase and Forming Nanoprecipitation to Improve the Mechanical Properties of Al-Si-Cu-Mg Alloy by Heat Treatment 期刊论文
ADVANCED ENGINEERING MATERIALS, 2021, 页码: 8
作者:  Hao, Jianfei;  Yu, Baoyi;  Bian, Jiancong;  Liu, Jinmin;  Sun, Wanting
收藏  |  浏览/下载：64/0  |  提交时间：2021/03/15
THE EFFECTS OF CALCIUM AND POTASSIUM DIHYDROGEN PHOSPHATE ON THE PROPERTIES OF MAGNESIUM OXYSULFATE CEMENTS 期刊论文
CERAMICS-SILIKATY, 2020, 卷号: 64, 期号: 1, 页码: 7-17
作者:  Luo, Kejia;  Wu, Chengyou;  Li, Zhen;  Liu, Panpan;  Pang, Ruiyang
收藏  |  浏览/下载：27/0  |  提交时间：2021/11/16
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：57/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Chemical Composition, Antibacterial, Cytotoxic and Antioxidant Activities of the Essential Oil of Malvastrum coromandelianum Aerial Parts 期刊论文
JOURNAL OF ESSENTIAL OIL BEARING PLANTS, 2019, 卷号: 22, 期号: 4, 页码: 1040-1047
作者:  Liu, Yuanji;  Su, Xiaodan;  Xiang, Yingxin;  Wang, Xueting;  Lai, Pengxiang
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/11

©版权所有 ©2017 CSpace - Powered by CSpace